Associated daily biosynthesis of cortisol and thromboxane A2: A preliminary report

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 1, 1996, Pages 115-121

  Fimognari, Filippo Luca ^a   Piccirillo, Gianfranco ^b   Lama, Jaime ^b   Paganica, Patrizia ^b   Monteleone, Girolamo ^b   Gianni, Walter ^b   Cacciafesta, Mauro ^b   Marigliano, Vincenzo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030199506     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90120-1     Document Type: Article

References (35)

1. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990;51(suppl VII):4-9.
2. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-25.
3. Axelrod J, Reisine TD. Stress hormones: their interaction and regulation. Science 1984;225:452-9.
4. Sachar EJ, Hellman L, Fukushima DK, Gallagher TF. Cortisol production in depressive illness: a clinical and biochemical clarification. Arch Gen Psychiatry 1970;23:289-98.
5. 2 in patients with depression. Am J Med Sci 1994;307:228-32.
6. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72:2994-8.
7. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 35:983-9.
8. Koudstaal PJ, Ciabattoni G, Van Gijn J, et al. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke 1993;24:219-23.
9. 2 metabolite excretion after thrombolysis. Am Heart J 1992;123:560-6.
10. The American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. (revised). Washington DC: APA Press, 1987.
11. WHO memorandum: classification of hyperlipidemias and hyperlipoproteinemias. Circulation 1972;45:501-8.
12. Spielberger CD, Gorsuch RL, Lushene RE. The state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologist Press, 1970.
13. 2 production in patients with systemic lupus erythematosus. J Clin Invest 1985;76:1011-8.
14. 125I radioimmunoassay of serum cortisol. Clin Chem 1978;24:1595-8.
15. Patrono C, Ciabattoni G, Pugliese F, Pierucci A, Blair IA, FitzGerald A. Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 1985;77: 590-4.
16. Vejar M, Fragasso G, Hackett D, et al. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb Haemost 1990;63:163-8.
17. Montalescot G, Drobinski G, Maclouf J, et al. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris. Circulation 1991;84:2054-62.
18. Davì G, Averna M, Catalano I, et al. Increased thromboxane biosynthesis in type IIA hypercholesterolemia. Circulation 1992;85:1792-8.
19. Emoto H, Tanaka M, Koga C, Yokoo H, Tsuda A, Yoshida M. Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain. Pharmacol Biochem Behav 1983;45:419-22.
20. Melia KR, Duman RS. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 1991;88: 8382-6.
21. Tsagarakis S, Holly JMP, Rees LH, Besser GM, Grossman A. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology 1988;123:1962-9.
22. Ardlie NG, McGuinness JA, Garrett JJ. Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis 1985;58:251-9.
23. O'Brien JR. Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature 1963;200: 763-4.
24. Hjemdahl P, Larson PT, Wallen NH. Effects of stress and beta-blockade on platelet function. Circulation 1991;84(suppl VI):VI44-61.
25. Larsson PT, Wallen NH, Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951-7.
26. Grignani G, Soffiantino F, Zucchella M, et al. Platelet activation by emotional stress in patients with coronary artery disease. Circulation 1991;83(suppl II):128-36.
27. Haft JI, Arkel YS. Effect of emotional stress on platelet aggregation in humans. Chest 1976;70:501-5.
28. 2 and prostacyclin. Stroke 1992;23:1400-3.
29. 2 and prostacyclin. Pharmacol Rev 1979;30:293-331.
30. Tsagakaris S, Gillies G, Rees LH, Besser GM, Grossman A. Interleukin-1 directly stimulates the release of corticotropin-releasing factor from rat hypothalamus. Neuroendocrinology 1989;49:98-101.
31. Revhaug A, Michie HR, Manson JM, et al. Inhibition of cyclooxygenase attenuates the metabolic response to endotoxin in humans. Arch Surg 1988;123:162-70.
32. Tewari A, Buhles WC Jr., Starnes HF Jr. Preliminary report: effects of interleukin-1 on platelet counts. Lancet 1990;336: 712-4.
33. Weitzman ED, Fukushima DK, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern of episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 1971;33:14-22.
34. Tofler GH, Brezinki D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-8.
35. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-43.